Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
SkinBioTherapeutics PLC - Newcastle Upon Tyne, England-based life science firm focused on skin health - Raises £4.2 million from the sale of 24.7 million new shares at 17 pence each. This is split between 24.1 million shares sold via placing and subscription, and 587,191 sold in an offer to retail investors. SkinBioTherapeutics announced the equity raise on Monday, saying it is to support an exclusive commercial agreement with Superdrug Stores PLC to roll-out AxisBiotix food supplements across the UK. The supplements are meant to alleviate inflammatory skin conditions.
Current stock price: 16.75p for £39.2 million market capitalisation
12-month change: up 72%
Copyright 2025 Alliance News Ltd. All Rights Reserved.